Study of XL999 in Patients With Acute Myeloid Leukemia (AML)

NCT00322673 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated due to cardiac toxicities

Conditions

Interventions

Sponsor

Symphony Evolution, Inc.